C1 esterase inhibitor (human) Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Nov 16, 2022.
C1 esterase inhibitor (human) is also known as: Berinert, Cinryze, Haegarda
C1 esterase inhibitor (human) Pregnancy Warnings
Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.
FDA pregnancy category: C
Use only if clearly needed and benefit outweighs potential risk.
C1 esterase inhibitor (human) Breastfeeding Warnings
Caution is recommended
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
The effects in the nursing infant are unknown.
See also
References for pregnancy information
- "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated (2022):
References for breastfeeding information
- "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated (2022):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.